(4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone

C36H45BrN4O7 — CID 25180965

IUPAC(4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone
SMILESC/C1=C\[C@H](C)C[C@H](C)OC(=O)C[C@H](c2ccc(O)cc2)NC(=O)[C@@H](C(O)c2c(Br)[nH]c3ccccc23)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)C1
InChIInChI=1S/C36H45BrN4O7/c1-19-15-20(2)17-22(4)48-29(43)18-28(24-11-13-25(42)14-12-24)40-35(46)31(41(6)36(47)23(5)38-34(45)21(3)16-19)32(44)30-26-9-7-8-10-27(26)39-33(30)37/h7-15,20-23,28,31-32,39,42,44H,16-18H2,1-6H3,(H,38,45)(H,40,46)/b19-15+/t20-,21-,22-,23-,28+,31+,32?/m0/s1
InChIKeyRGEDKIOYAMGHKE-JMZVJJFWSA-N
MW725.68 g/mol
LogP5.19
Rot. Bonds3

About (4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone

(4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone (PubChem CID 25180965) has the molecular formula C36H45BrN4O7 and a molecular weight of 725.68 g/mol. Its IUPAC name is (4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone.

Molecular Properties

Compound Name(4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone
PubChem CID25180965
Molecular FormulaC36H45BrN4O7
Molecular Weight725.68 g/mol
Exact Mass724.25
IUPAC Name(4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone
SMILESC/C1=C\[C@H](C)C[C@H](C)OC(=O)C[C@H](c2ccc(O)cc2)NC(=O)[C@@H](C(O)c2c(Br)[nH]c3ccccc23)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)C1
InChIInChI=1S/C36H45BrN4O7/c1-19-15-20(2)17-22(4)48-29(43)18-28(24-11-13-25(42)14-12-24)40-35(46)31(41(6)36(47)23(5)38-34(45)21(3)16-19)32(44)30-26-9-7-8-10-27(26)39-33(30)37/h7-15,20-23,28,31-32,39,42,44H,16-18H2,1-6H3,(H,38,45)(H,40,46)/b19-15+/t20-,21-,22-,23-,28+,31+,32?/m0/s1
InChIKeyRGEDKIOYAMGHKE-JMZVJJFWSA-N
XLogP5.19
TPSA161.06 Ų
H-Bond Donors5
H-Bond Acceptors7
Rotatable Bonds3
Heavy Atoms48
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500725.68
LogP ≤ 55.19
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone?
The IUPAC name of (4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone (CID 25180965) is (4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone.
What is the SMILES notation for (4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone?
The canonical SMILES for (4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone is C/C1=C\[C@H](C)C[C@H](C)OC(=O)C[C@H](c2ccc(O)cc2)NC(=O)[C@@H](C(O)c2c(Br)[nH]c3ccccc23)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)C1.
What is the InChIKey of (4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone?
The InChIKey is RGEDKIOYAMGHKE-JMZVJJFWSA-N. The full InChI is InChI=1S/C36H45BrN4O7/c1-19-15-20(2)17-22(4)48-29(43)18-28(24-11-13-25(42)14-12-24)40-35(46)31(41(6)36(47)23(5)38-34(45)21(3)16-19)32(44)30-26-9-7-8-10-27(26)39-33(30)37/h7-15,20-23,28,31-32,39,42,44H,16-18H2,1-6H3,(H,38,45)(H,40,46)/b19-15+/t20-,21-,22-,23-,28+,31+,32?/m0/s1.
What are the key properties of (4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone?
(4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone has a molecular weight of 725.68 g/mol, XLogP of 5.19, 3 rotatable bonds, 5 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (4R,7R,10S,13S,15E,17R,19S)-7-[(2-bromo-1H-indol-3-yl)-hydroxymethyl]-4-(4-hydroxyphenyl)-8,10,13,15,17,19-hexamethyl-1-oxa-5,8,11-triazacyclononadec-15-ene-2,6,9,12-tetrone is sourced from PubChem (CID 25180965), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).